DUBLIN–(BUSINESS WIRE)–The “Global In-Silico Drug Discovery Market: Focus on Products, Technologies, Workflow, End Users, Country Data (17 Countries), and Competitive Landscape – Analysis and Forecast, 2018-2029” report has been added to ResearchAndMarkets.com’s offering.
The in-silico drug discovery industry analysis projects the market to grow at a significant CAGR of 12.92% during the forecast period, 2019-2029.
Key Questions Answered in this Report:
- What are the major market drivers, challenges, and opportunities in the global in-silico drug discovery market?
- What are the underlying structures resulting in the emerging trends within the global in-silico drug discovery market?
- How is each segment of the global in-silico drug discovery market expected to grow during the forecast period and what is the estimated revenue to be generated by each of the segments by the end of 2029?
- What is the expected compound growth rate to be witnessed by the leading players in the market during the forecast period 2019-2029?
- What are the key applications in the global in-silico drug discovery market? What are the major segments of these applications?
- Who are the key manufacturers of the global in-silico drug discovery market, and what are their contributions?
Global In-Silico Drug Discovery Market Forecast, 2019-2029
The in-silico drug discovery market generated $2,094.5 million in revenue in 2018, in terms of value. The global in-silico drug discovery market growth has been primarily attributed to the major drivers in this market such as an emphasis on the reduction in medical errors and readmission rates, growth in the biomarker identification market and advancements in In-silico drug discovery techniques, and computational technological advancements in the field of computational biology. However, there are significant challenges that are restraining the market growth. These challenges include the high cost of methods and expensive procedures and their applications in medical treatments.
Scope of the Market Intelligence on the In-Silico Drug Discovery Market
The in-silico drug discovery research provides a holistic view of the market in terms of various factors influencing it, including regulatory reforms, and technological advancements.
The scope of this report is centered upon conducting a detailed study of the products and manufacturers allied with the service market. In addition, the study also includes exhaustive information on the unmet needs, perception of the new products, competitive landscape, market share of leading manufacturers, the growth potential of each underlying sub-segment, and company, as well as other vital information with respect to the global in-silico drug discovery market.
Key Topics Covered:
1 Product Definition
1.1 Inclusion and Exclusion
2 Research Scope
2.1 Scope of the Study
2.2 Key Questions Answered in the Report
3 Research Methodology
3.1 Global In-Silico Drug Discovery Market: Research Methodology
3.2 Primary Data Sources
3.3 Secondary Data Sources
3.4 Market Estimation Model
4 Industry Analysis
4.1 Regulatory Framework
4.1.1 Regulatory Framework in North America
4.1.2 Regulatory Framework in Europe
4.1.3 Regulatory Framework in Asia-Pacific
5 Competitive Landscape
5.1 Mergers and Acquisitions
5.2 Product Launches and Product Updates
5.3 Synergistic Activities
5.4 Business Expansion Activities and Others
5.5 Market Share Analysis
6 Market Dynamics
6.1 Overview
6.2 Impact Analysis
6.3 Market Drivers
6.4 Market Restraints
6.5 Market Opportunities
7 In-Silico Drug Discovery: Overview
7.1 Introduction
7.2 Market Availability for In-Silico Drug Discovery
7.3 In-Silico Drug Discovery Market Technology Trends
8 Global In-Silico Drug Discovery Market (by Workflow)
8.1 Overview
8.2 Discovery
8.3 Pre-Clinical Tests
8.4 Clinical Trials
9 Global In-Silico Drug Discovery Market (by Product)
9.1 Software
9.2 Software as a Service (Cloud)
9.3 Consultancy as a Service
10 Global In-Silico Drug Discovery Market (by Software Type)
10.1 Molecular Modeling and de Novo Drug Design Software
10.2 Pharmacophore Modeling Software
11 Global In-Silico Drug Discovery Market (by End User)
11.1 Contract Research Organizations
11.2 Pharmaceutical Industry
11.3 Academic and Research Institutes
11.4 Other End Users (Hospitals and Other Care Facilities)
12 Global In-Silico Drug Discovery Market, by Region
12.1 Overview
12.2 North America
12.3 Europe
12.4 Asia-Pacific
12.5 Latin America
12.6 Rest-of-the-World
13 Company Profiles
13.1 Overview
13.2 Albany Molecular Research Inc.
13.3 Certara USA, Inc.
13.4 Charles River
13.5 Chemical Computing Group ULC
13.6 Collaborative Drug Discovery Inc.
13.7 Dassault System
13.8 Evotec A.G.
13.9 GVK Biosciences Private Limited
13.10 ICAGEN, INC.
13.11 Novo Informatics Pvt. Ltd.
13.12 Numerate, Inc.
13.13 PerkinElmer, Inc.
13.14 Schrdinger, LLC
13.15 Selvita
13.16 Simulation Plus
13.17 WuXi AppTec
13.18 e-therapeutics plc (Snapshot)
For more information about this report visit https://www.researchandmarkets.com/r/ev3mhy
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900